Connecting cytokines and brain: A review of current issues

Histology and Histopathology

Volumn 17, Issue 1, 2002, Pages 273-288

  Quan, Ning ^a   Herkenham, M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

IL 1; Neurodegeneration; Neuroimmune communication; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR MODIFICATION; BLOOD BRAIN BARRIER; BRAIN INFECTION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM FUNCTION; CHRONIC FATIGUE SYNDROME; DISEASE COURSE; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGICAL PARAMETERS; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; MODULATION; NERVE CELL MEMBRANE POTENTIAL; NERVE DEGENERATION; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PUBLISHING; REGULATORY MECHANISM; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CYTOKINES; HUMANS; NERVE DEGENERATION; NERVE NET; NERVOUS SYSTEM DISEASES; SIGNAL TRANSDUCTION;

EID: 0036165085     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (226)

1. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
2. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children
3. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes
4. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
5. Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei
6. Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice: Assessment with species- specific enzyme immunoassays
7. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier
8. Permeability of the blood-brain barrier to soluble cytokine receptors
9. Passage of cytokines across the blood-brain barrier
10. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus
11. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
12. Neuroendocrine and metabolic responses induced by interleukin-1
13. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
14. Role of the anteroventral third ventricle region in fever in sheep
15. Activation of acute-phase responses by intrapreoptic injections of endogenous pyrogen in guinea pigs
16. Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs
17. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
18. Hypothalamic neurons. Mechanisms of sensitivity to temperature
19. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain
20. Interleukin-1 immunoreactive innervation of the human hypothalamus
21. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
22. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism
23. Mechanisms of immune injury in multiple sclerosis
24. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
25. Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rate brain microglial cells
26. Cytokine regulation of B-cell growth and differentiation
27. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system
28. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: A possible site of prostaglandin synthesis responsible for fever
29. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice
30. SOD-1 transgenic mice as a model for studies of neuroprotection in stroke and brain trauma
31. Aphagic and adipsic effects of interleukin-1
32. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
33. Glia, cytokines, and neurotoxicity
34. Modulation of human microglial cell superoxide production by cytokines
35. Glia: The not so innocent bystanders
36. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-metyl-D-aspartate receptors
37. Cytokine-stimulated astrocyte damage human neurons via a nitric oxide mechanism
38. A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma
39. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
40. Cytokine pathways and joint inflammation in rheumatoid arthritis
41. Prostalandin E2 in the pathogenesis of fever. An update
42. Interferon-beta not only inhibits interleukin-1 beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells
43. Behavioural effects of peripherally injected interleukin-1: Role of prostaglandins
44. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro
45. Distribution of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus infected trigeminal ganglia in the mouse
46. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse
47. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury
48. Macrophage inflammmatory protein-1: A prostaglandin-independent endogenous pyrogen
49. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM)
50. Production of endogenous pyrogen
51. Interleukins
52. Mechanisms of fever induced by recombinant human interferon
53. The pyrogenic and mitogenic actions of interleukin-1 are related
54. Human African trypanosomiasis
55. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone
56. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1
57. Stress- and endototoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity
58. The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia
59. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons
60. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1
61. Type 1 interleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation
62. Visualization and characterization of interleukin 1 receptors in brain
63. Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated
64. Immune-mediated injury in bacterial meningitis
65. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes
66. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion
67. Juvenile parkinsonism caused by chronic meningoencephalitis: A clinicopathological study
68. IL1 beta impairs relational but not procedural rodent learning in a water maze task
69. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization
70. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication
71. Interleukin-1beta in immune cells of the abdominal vagus: A link between the immune and nervous systems?
72. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice
73. Brainn interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
74. Microglial interleukin-1 alpha expression in human head injury: Correlations with neuronal and neuritic beta-amyloid precursor protein expression
75. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
76. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1 beta
77. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever
78. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose
79. Fever, temperature, and the immune response
80. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
81. Action site of circulating interleukin-1 on the rabbit brain
82. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6
83. Cytokine combinations in immunotherapy for solid tumors: A review
84. Neurochemical correlates of parkinsonism. Role of dopaminergic lesions
85. Tumor necrosis factor identified in multiple sclerosis brain
86. Effects of temperature and neuroactive substances on hypothalamic neurones in vitro: Possible implications for the induction of fever
87. Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothalamic neurons
88. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis
89. IL-1beta immunoreactive neurons in the human hypothalamus: Reduced numbers in multiple sclerosis
90. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease
91. An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever
92. Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin
93. Brainstem projections of sensory and motor components of the vagus nerve in the rat
94. Tumor necrosis factor-beta induces sleep, fever, and anorexia
95. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments
96. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
97. Mechanisms of sickness-induced decreases in food-motivated behavior
98. Somnogenic effects of rabbit and recombinant human interferons in rabbits
99. Fever and survival
100. Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis
101. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; A functional anatomical analysis
102. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice
103. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice
104. Sleep-promoting effects of endogenous pyrogen (interleukin-1)
105. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
106. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain
107. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS
108. Immunoreactive interleukin-1β localization in the rat forebrain
109. Area postrema removal abolishes stimulatory effects of intravenous interleukin-1beta on hypothalamic-pituitary-adrenal axis activity and c- fos mRNA in the hypothalamic paraventricular nucleus
110. Interleukin-1, nitric oxide and reactive astrocytes
111. Role of interleukin 6 in fever in rats
112. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice
113. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts
114. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study
115. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat
116. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat
117. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat
118. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist
119. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits
120. Relative contributions of a CVO and the microvascular bed to delivery of blood-borne IL-1 alpha to the brain
121. The human subfornical organ: An anatomic and ultrastructural study
122. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage
123. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies
124. Endogenous neuroprotection factors and traumatic brain injury: Mechanisms of action and implications for therapy
125. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease
126. Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats
127. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
128. Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro
129. Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients
130. Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat
131. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia
132. A neuropathologic analysis of neonatal deaths occurring in a single neonatal unit over a 20-year period
133. A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion
134. Rel/NF-κB/I κB story
135. Expression of cytokines during glial differentiation
136. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
137. Interleukin (IL)-1, beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
138. Specificity of interleukin-1 beta-induced changes in monoamine concentrations in hypothalamic nuclei: Blockade by interleukin-1 receptor antagonist
139. Distribution of interleukin 1 beta immunoreactivity within the porcine hypothalamus
140. Differential roles of cytokine signaling during T-cell development
141. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease
142. + microglia, but not primary IL-1α+ microglia, increase with age in normal human brain
143. Aging-associated changes in human brain
144. Rationale for early treatment with interferon beta-1α in relapsing-remitting multiple sclerosis
145. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis
146. Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge
147. Interleukin-1 beta production in the rabbit brain during endotoxin-induced fever
148. Origin, proliferation, and fate of cerebrospinal fluid cells. A review on cerebrospinal fluid cell kinetics
149. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons
150. The cytokine network
151. Chemical and neuronal control of feeding motivation
152. Somnogenic and pyrogenic effects of interleukin-1beta and lipopolysaccharide in intact and vagotomized rats
153. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2
154. Pentoxifylline suppression of TNF-alpha mediated axonal degeneration in the rabbit optic nerve
155. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
156. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines
157. Abdominal vagotomy does not modify endotoxic shock in rats
158. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
159. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration
160. 14C]inulin in rat
161. Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation
162. Brain cytokine expression in response to peripheral infection
163. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide
164. Induction of inhibitory factor κBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: An in situ hybridization histochemistry study in the rat
165. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide
166. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide
167. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat
168. Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei
169. Chronic sodium salicylate treatment exacerbates brain neurodegeneration in rats infected with Trypanosoma brucei
170. The immune system and memory consolidation: A role for the cytokine IL-1beta
171. Multiple sclerosis: Immune system molecule expression in the central nervous system
172. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor
173. Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma
174. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
175. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli
176. Continuous infusion of interleukin-2 in children with refractory malignancies
177. The vagus nerve in the thermoregulatory response to systemic inflammation
178. Recent advances in cytokines, cytokine receptors and signal transduction
179. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain
180. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta
181. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
182. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta
183. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice
184. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor
185. Spread of Trypanosoma brucei to the nervous system: Early attack on circumventricular organs and sensory ganglia
186. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain
187. Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pig
188. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
189. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I
190. The central neural connections of the area postrema of the rat
191. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity
192. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
193. Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices
194. Cytokine production in the brain following closed head injury: Dexanabinol (Hu-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant
195. Signaling the brain in systemic inflammation: Which vagal branch is involved in fever genesis?
196. Neurological effects of recombinant human interferon
197. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment
198. Clinical studies with tumour necrosis factor
199. Anit-inflammatory cytokines and cytokine antagonists
200. Evidence for the involvement of the organum vasculosum laminae terminalis in the febrile response of rabbits and rats
201. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: Involvement of nerve growth factor
202. Cortical protection by localized striatal injection of IL-1a following cerebral ischemia in the rat
203. Endotoxin fever in the new-born guinea-pig and the modulating effects of indomethacin and p-chlorophenylalanine
204. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis
205. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand
206. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
207. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta
208. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: A pathway for the induction of non-specific symptoms of sickness?
209. Endotoxin-induced apperance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study
210. Immunocytochemical detection of prostaglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin
211. Interleukin-1 receptors on rat brain endothelial cells: A role in neuroimmune interaction?
212. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningoccocal infections
213. The cytokine network and immune functions
214. Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells
215. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system
216. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia
217. Characterization of cytokine-induced hyperalgesia
218. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia
219. Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia
220. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism
221. In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the brain
222. Possible involvement of interleukin-1 in ischemic brain edema formation
223. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury
224. Identification of the promoter region of human interleukin 1 type I receptor gene: Multiple initiation sites, high G+C content, and constitutive expression
225. Interleukin (IL)-6 release and fever induced by a pre-formed pyrogenic factor (PFPF) derived from LPS-stimulated macrophages
226. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion